137 related articles for article (PubMed ID: 9426742)
21. Role of the c-myc proto-oncogene in the proliferation of hereditary gingival fibromatosis fibroblasts.
Tipton DA; Woodard ES; Baber MA; Dabbous MKh
J Periodontol; 2004 Mar; 75(3):360-9. PubMed ID: 15088873
[TBL] [Abstract][Full Text] [Related]
22. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
23. Antisense c-myc retroviral vector suppresses established human prostate cancer.
Steiner MS; Anthony CT; Lu Y; Holt JT
Hum Gene Ther; 1998 Mar; 9(5):747-55. PubMed ID: 9551622
[TBL] [Abstract][Full Text] [Related]
24. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines.
Kampa M; Hatzoglou A; Notas G; Damianaki A; Bakogeorgou E; Gemetzi C; Kouroumalis E; Martin PM; Castanas E
Nutr Cancer; 2000; 37(2):223-33. PubMed ID: 11142097
[TBL] [Abstract][Full Text] [Related]
25. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
Wang H; Yu D; Agrawal S; Zhang R
Prostate; 2003 Feb; 54(3):194-205. PubMed ID: 12518324
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells.
Yeh JY; Huang WJ; Kan SF; Wang PS
J Urol; 2001 Nov; 166(5):1937-42. PubMed ID: 11586264
[TBL] [Abstract][Full Text] [Related]
28. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
[TBL] [Abstract][Full Text] [Related]
29. Oligonucleotide biological activity: relationship to the cell cycle and nuclear transport.
Wu-Pong S; Bard J; Huffman J; Jimerson J
Biol Cell; 1997 Jul; 89(4):257-61. PubMed ID: 9447700
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.
Eder IE; Culig Z; Ramoner R; Thurnher M; Putz T; Nessler-Menardi C; Tiefenthaler M; Bartsch G; Klocker H
Cancer Gene Ther; 2000 Jul; 7(7):997-1007. PubMed ID: 10917202
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts.
Pinski J; Parikh A; Bova GS; Isaacs JT
Cancer Res; 2001 Sep; 61(17):6372-6. PubMed ID: 11522628
[TBL] [Abstract][Full Text] [Related]
32. Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers.
Santhakumaran LM; Thomas T; Thomas TJ
Nucleic Acids Res; 2004; 32(7):2102-12. PubMed ID: 15087489
[TBL] [Abstract][Full Text] [Related]
33. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
34. C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes.
Hashiramoto A; Sano H; Maekawa T; Kawahito Y; Kimura S; Kusaka Y; Wilder RL; Kato H; Kondo M; Nakajima H
Arthritis Rheum; 1999 May; 42(5):954-62. PubMed ID: 10323451
[TBL] [Abstract][Full Text] [Related]
35. c-Myc antisense oligonucleotides preserve smooth muscle differentiation and reduce negative remodelling following rat carotid arteriotomy.
Forte A; Galderisi U; De Feo M; Gomez MF; Esposito S; Santè P; Renzulli A; Agozzino L; Hellstrand P; Berrino L; Cipollaro M; Cotrufo M; Rossi F; Cascino A
J Vasc Res; 2005; 42(3):214-25. PubMed ID: 15849475
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
Watson PH; Pon RT; Shiu RP
Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215
[TBL] [Abstract][Full Text] [Related]
37. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
Miyake H; Chi KN; Gleave ME
Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
[TBL] [Abstract][Full Text] [Related]
38. Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivation.
Mu Z; Hachem P; Agrawal S; Pollack A
Prostate; 2004 Aug; 60(3):187-96. PubMed ID: 15176048
[TBL] [Abstract][Full Text] [Related]
39. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis.
Maramag C; Menon M; Balaji KC; Reddy PG; Laxmanan S
Prostate; 1997 Aug; 32(3):188-95. PubMed ID: 9254898
[TBL] [Abstract][Full Text] [Related]
40. Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides.
Gleave ME; Miayake H; Goldie J; Nelson C; Tolcher A
Urology; 1999 Dec; 54(6A Suppl):36-46. PubMed ID: 10606283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
